A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)
Clinical trial NCT00627926 · COMPLETED
Trial details
- NCT number
- NCT00627926
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 1095
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.